Page last updated: 2024-10-28

miltefosine and Cancer of Liver

miltefosine has been researched along with Cancer of Liver in 2 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Research Excerpts

ExcerptRelevanceReference
"34 patients with metastatic colorectal cancer were treated with the ether lipid miltefosine (hexadecylphosphocholine)."9.07Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer. ( Planting, AS; Stoter, G; Verweij, J, 1993)
"34 patients with metastatic colorectal cancer were treated with the ether lipid miltefosine (hexadecylphosphocholine)."5.07Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer. ( Planting, AS; Stoter, G; Verweij, J, 1993)
"Patients with liver cirrhosis of different aetiologies are at a risk to develop HCC."2.66Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. ( Aslanidis, C; Buechler, C, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Buechler, C1
Aslanidis, C1
Planting, AS1
Stoter, G1
Verweij, J1

Reviews

1 review available for miltefosine and Cancer of Liver

ArticleYear
Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma.
    Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020, Volume: 1865, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Prolif

2020

Trials

1 trial available for miltefosine and Cancer of Liver

ArticleYear
Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:4

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Leuk

1993